New research indicates that patients who discontinue popular GLP-1 drugs like Wegovy and Mounjaro tend to recover lost weight much more quickly than those who stop traditional lifestyle regimens.
Findings released in a prominent medical journal demonstrates that while overweight people frequently drop about a fifth of their total mass while on the medication, the mass returns at an estimated rate of nearly a kilo each month after stopping.
"Users using these medications need to be cognizant of the potential of rapid weight regain when the medication ends," warns researcher Dr. Susan Jebb.
That rate of recovery suggests a return to pre-treatment weight in about 18 months.
Weighing Treatments
The study, which looked at 37 of studies involving over 9,000 of participants, contrasted the outcomes of the injectable medications with other pills.
Researchers note that individuals who lose weight through dieting generally experience a slower weight regain—approximately 100 grams monthly—post-intervention.
Understanding the Quick Rebound
Nutrition scientists propose the mechanism of the jabs accounts for the accelerated weight return.
GLP-1 drugs imitate a natural hormone called GLP-1, which controls appetite.
"Sustained high doses of GLP-1 concentrations several times higher than normal may cause the body to produce less of its endogenous hormone, and may also diminish responsiveness to its effects," said Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this hormone supplement results in hunger is no longer kept in check, making binge eating much more probable."
A Lifelong Condition?
Medical guidelines advise the jabs for individuals with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications.
A number of clinicians say that, considering the high risk of weight regain, the therapy might need to be life-long.
This perspective is reinforced by drug manufacturers, who say that the findings "underscore the chronic character of obesity," akin to managing conditions like diabetes.
User Accounts
Individuals who have come off the jabs describe a intense resurgence of cravings.
"It felt as if a switch flipping and I was suddenly starving," recalled a patient.
This difficulty is compounded if individuals have not established sustainable lifestyle or habit changes during therapy.
Significant Interest
Survey data indicate that millions of people in the UK have tried these injections in the last 12 months, with desire continuing to grow.
- Use is more common among women than males.
- The 40s and 50s demographic shows the greatest usage rates.
- A large proportion obtain the drugs through private healthcare rather than the NHS.
Ultimately, clinicians emphasize that while GLP-1 drugs are potent tools for shedding pounds, they are not a standalone fix and maintained weight loss hinges on integrated lifestyle changes.
